drugset / Trial / NCT00075894
Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as alanosine, use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase I trial is studying the side effects and best dose of alanosine in treating patients with high-grade progressive or recurrent malignant gliomas.
Timeline
- Start
- 2004-03
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | alanosine | Small molecule | — | Intravenous |
| Subject | alanosine | Small molecule | — | — |